Kraig Biocraft Laboratories Launches New Website
July 21 2013 - 11:05PM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the
leading developer of advanced spider silk based fibers, today
announced the launch of its entirely new website,
www.kraiglabs.com.
"Although we've worked with cutting-edge biotech companies in
the past, our whole team was fascinated by the incredible things
Kraig Biocraft is achieving in the labs," commented Jonathan Keim,
owner of GPGSolutions. "We truly enjoyed working with the Company
and being a part of its exciting story."
"As we move toward the commercialization of recombinant spider
silks, it is important that we build our band and our image," said
Company CEO and founder, Kim K Thompson. "With Jonathan's help, we
built a website from the ground up, to better highlight the
Company's high-tech foundations and enhance our public image. The
new and improved website is also part of our plan to improve
communication with prospective partners, customers and our
shareholders. We hired GPGSolutions' because of their stellar
reputation and their enthusiasm for the project. Their
creativity, responsiveness and technical ability worked to produce
a platform that better represents our vision and promotes our
brand."
Shareholders and interested persons who have not already done
so, are invited to subscribe to the Company's email updates in
advance of the launch of that program. The sign in button can
be found at the bottom of the Investors page of the Company
website.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Apr 2023 to Apr 2024